Cornell Cancer & Oncology Research

80 recent oncology and cancer research papers authored by Cornell University faculty and affiliates, drawn from arXiv, newest first.

• CAR T cells take on precancers2026-06-17
  Sham Mailankody
  arXiv ↗
• Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy2026-06-15
  Carlo Bosi
  arXiv ↗
• Associations of alcohol use with expression of stromal markers in benign breast biopsy samples2026-06-11
  Rulla M. Tamimi
  arXiv ↗
• Examining bidirectional longitudinal relationships between physical activity and physical function in older breast cancer survivors: The Thinking and Living with Cancer study2026-06-10
  Eunji Choi
  arXiv ↗
• Recent Trends in Race and Ethnicity Reporting in Breast Surgery Journals2026-06-10
  X Ma, Lisa Newman
  arXiv ↗
• The Diagnostic Utility of PRAME in a Case of Trans-Differentiated Melanoma Metastatic to the Heart2026-06-09
  Carla Stephan, José Jessurun
  arXiv ↗
• Benchmarking urinary cell transcriptomes for noninvasive differentiation of BK polyomavirus–associated nephropathy from T cell–mediated rejection2026-06-08
  Franco B. Mueller, Carol Li, Darshana M. Dadhania, Surya V. Seshan, Thalia Salinas, Vijay K. Sharma, JZ Xiang, Thangamani Muthukumar, Manikkam Suthanthiran
  arXiv ↗
• Preclinical discovery and clinical development of glofitamab in relapsed/ refractory large B-cell lymphomas2026-06-07
  Gilles Salles
  arXiv ↗
• Epithelial-mesenchymal transition and immunosuppression: Two sides of the same coin2026-06-06
  Brian Feng, Anushka Dongre
  arXiv ↗
• Recent Developments in the Diagnosis and Treatment of Disseminated and Rare Melanoma with Radiotheranostics2026-06-05
  Jason S. Lewis, Nagavarakishore Pillarsetty
  arXiv ↗
• Brief Review: Rethinking Colonic Redundancy in Gastroenterology2026-06-05
  Réka G. Szigeti, Eamonn M. M. Quigley
  arXiv ↗
• Novel technologies for gastrointestinal cancer detection: a systematic review and meta-analysis of diagnostic accuracy2026-06-04
  S A Alqahtani
  arXiv ↗
• Updated outcomes from STAMP: Surgically treated adjuvant Merkel cell carcinoma with pembrolizumab, a phase III trial—ECOG-ACRIN EA6174.2026-06-03
  Jedd D. Wolchok
  arXiv ↗
• Human expertise or artificial intelligence? A prospective study on nail disorder diagnosis2026-06-02
  Shari R. Lipner
  arXiv ↗
• Practical Guide to Address Common Myths in the Pre- and Post-kidney Transplant Management of the Elderly Patient with Cancer: An Opinion Paper.2026-06-01
  Darshana M Dadhania
  arXiv ↗
• Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus‐Associated Disorders2026-06-01
  Jeanne Jiang, Ethel Cesarman
  arXiv ↗
• Emerging role of antibody–drug conjugates in gastrointestinal malignancies2026-06-01
  Uqba Khan, Manish A. Shah
  arXiv ↗
• Adjuvant Nivolumab vs Observation in Resected Non–Small Cell Lung Cancer2026-06-01
  Jamie E. Chaft, Charles M. Rudin
  arXiv ↗
• No difference in recurrence rates between wide local excision and amputation for acral lentiginous melanoma: A systematic review and meta-analysis2026-06-01
  Shari R. Lipner
  arXiv ↗
• Critical role of keratinocytes and protease‐activated receptor 2 in secondary lymphedema development2026-06-01
  Cristina C. Clement, Laura Santambrogio
  arXiv ↗
• Transcriptomic regulation of pancreatic acinar cell homeostasis and plasticity2026-06-01
  Christopher Luo
  arXiv ↗
• The Experience of Depression in Older Adults With Cancer: A Qualitative Descriptive Analysis2026-06-01
  Madeleine M. Hardt, Jo Anne Sirey
  arXiv ↗
• Antibody-drug conjugates in precision oncology2026-06-01
  Sarat Chandarlapaty
  arXiv ↗
• Safety and effectiveness of the Colovac anastomosis protection device compared with diverting ileostomy after low anterior resection: protocol for an international, multicentre, prospective, non-randomised comparative study (SAFE-3)2026-06-01
  Mehraneh D Jafari
  arXiv ↗
• Reducing the Burden Through Early Detection: Health-Economic Impact of Gastrointestinal Cancers in Saudi Arabia2026-06-01
  Saleh A. Alqahtani
  arXiv ↗
• Impact of Bridging Response on Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma2026-06-01
  Michael Scordo, Gunjan L. Shah, Sergio Giralt, Miguel‐Angel Perales, Gilles Salles, Roni Shouval, M. Lia Palomba
  arXiv ↗
• Organoid-T cell co-cultures functionally stratify tumor-reactive T cells and their responses to immune checkpoint inhibitors2026-05-31
  Shalini Nath, B.J. Hopkins
  arXiv ↗
• AI‐Designed Cyclic Peptides Enable Controllable Modulation of the CD28 Immune Checkpoint2026-05-30
  Katarzyna Kuncewicz, Saurabh Upadhyay, Moustafa Gabr
  arXiv ↗
• Type II tRNA cleavage by SLFN14 endoribonuclease variants linked to inherited thrombocytopenia drives global translational repression2026-05-29
  Xinyi Ashley Liu, Saori Uematsu, Shu-Bing Qian
  arXiv ↗
• Active endothelial and neural regulation of valve biology, health, and disease2026-05-29
  G Janani, Kayla Nguyen, Jonathan T. Butcher
  arXiv ↗
• CD4 T-cell reconstitution and CD4:CD8 inversion following lymphodepleting chemotherapy for tumor-infiltrating lymphocyte therapy in metastatic melanoma.2026-05-28
  Barbara T. Ma
  arXiv ↗
• Real-world safety of adoptive cellular therapy with lifileucel in patients with advanced melanoma.2026-05-28
  Barbara T. Ma
  arXiv ↗
• Pre-diagnostic imaging and radiology report–based risk modeling for pancreatic ductal adenocarcinoma.2026-05-28
  Hexin Dong, Yifan Peng, G L Shih
  arXiv ↗
• A phase Ia/Ib trial of FAP-Dox (AVA6000), a fibroblast activation protein (FAP)–released doxorubicin peptide drug conjugate in patients with FAP-positive solid tumors and activity against salivary gland cancers.2026-05-28
  W. Tap
  arXiv ↗
• Activity of NP-G2-044 (fascin inhibitor) + anti–PD-1 in ICI-resistant advanced/metastatic solid tumors with expansion in cutaneous squamous cell carcinoma (CSCC).2026-05-28
  Xin‐Yun Huang
  arXiv ↗
• Anti–PD-(L)1 plus chemotherapy in advanced PD-L1–negative nonsquamous non–small cell lung cancer: A systematic review and meta-analysis.2026-05-28
  Alexander E. Drilon
  arXiv ↗
• Comparative analysis of national cancer policy among low-income, low-middle-income, and high-middle-income countries.2026-05-28
  Syeda Akila Ally
  arXiv ↗
• SARC045: A phase 2 trial of tebentafusp in HLA-A*02:01–positive patients with advanced clear cell sarcoma.2026-05-28
  Sandra P. D'Angelo
  arXiv ↗
• Tumor evolution following treatment with sacituzumab govitecan for metastatic breast cancer: A proteomic analysis.2026-05-28
  Komal L. Jhaveri
  arXiv ↗
• Monitoring PD-L1 expression in circulating cancer associated cells for prediction of clinical outcomes in metastatic breast cancer patients treated with immune checkpoint inhibitors.2026-05-28
  M Cristofanilli, Carolina Reduzzi
  arXiv ↗
• Liquid biopsy to stratify metastatic breast cancer progression risk using multi-analyte cell subtyping prior to systemic therapy.2026-05-28
  M Cristofanilli, Carolina Reduzzi
  arXiv ↗
• Stratifying survival benefit of encorafenib/cetuximab (EC) in BRAF V600E–mutant mCRC using clinical and inflammatory biomarkers: Real-world experience from greater Manchester.2026-05-28
  Panagiotis J. Vlachostergios
  arXiv ↗
• Safety and efficacy of daraxonrasib monotherapy as later-line (3L+) treatment for patients (pts) with metastatic pancreatic adenocarcinoma (PDAC).2026-05-28
  Wungki Park
  arXiv ↗
• TREGCHECK 102: A study of tagmokitug (CHS-114) in combination with toripalimab and/or other treatments in participants with advanced solid tumors.2026-05-28
  Yelena Y. Janjigian
  arXiv ↗
• Comprehensive genomic profiling of patients with cancer of unknown primary (CUP).2026-05-28
  Panagiotis J. Vlachostergios
  arXiv ↗
• <i>MACROD2</i> and <i>CDKN2A</i> in multiple myeloma: Insights to germline susceptibility and cytogenetic risk from long-read Nanopore sequencing.2026-05-28
  Rohan Sarkar
  arXiv ↗
• Immune-mediated toxicities (irAEs) in immune checkpoint inhibitor (ICI) therapy in various combinations: A real-world sample.2026-05-28
  Neil J. Shah
  arXiv ↗
• Don’t ask, don’t tell: Missing ECOGS and anticancer treatment, neutrophil-to-lymphocyte ratios, and outcomes in hospitalized patients with solid tumors.2026-05-28
  Holly G. Prigerson, Christine A. Garcia, Ann Rosen, Lindsay Lief, David Berlin, Silvia C. Formenti, Rutika Mehta, Rachel Ann Oshins, Julia Rebecca Sobel, Madiso
  arXiv ↗
• Randomized multicenter phase II trial of radioimmunotherapy versus chemoimmunotherapy followed by surgery for c-stage IB-III NSCLC (RICHIS trial).2026-05-28
  Jonathan Villena-Vargas, Jeffrey L. Port, Dan Jones, Oliver S. Chow, S. Harrison, Benjamin E. Lee, Christine A. Garcia, Ashish Saxena, Nicholas J Sanfilippo, D.
  arXiv ↗
• Efficacy prediction for progression-free survival (PFS) and overall survival (OS) by genomic instability score (GIS) cutoffs in patients (pts) with advanced ovarian cancer (aOC): Post hoc results from the phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial.2026-05-27
  Roisin Eilish O'Cearbhaill
  arXiv ↗
• Immune priming with the EZH2 inhibitor tazemetostat in B-cell lymphomas receiving CAR T-cell therapy.2026-05-27
  Samuel Yamshon, Caitlin Gribbin, Yusuke Isshiki, Ioannis Karagiannidis, Sunjae Lee, Jizhi Yan, Gwynne Ozkan, Anna Alperovich, Barbara T. Ma, Christopher Hackett
  arXiv ↗
• Format matters: Digital vs print delivery of a job retention intervention during breast cancer therapy.2026-05-27
  Shoshana M. Rosenberg
  arXiv ↗
• KEYNOTE-811: 6-year median follow-up of pembrolizumab plus trastuzumab and chemotherapy for previously untreated advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma.2026-05-27
  Yelena Y. Janjigian
  arXiv ↗
• Oncologic outcomes following biologic therapy for immune-related cutaneous adverse events.2026-05-27
  Michael A. Postow, Neil J. Shah
  arXiv ↗
• Survivorship-focused content at the American Society of Clinical Oncology (ASCO) 2022-2024 annual meetings.2026-05-27
  Christine A. Garcia
  arXiv ↗
• Effect of a weight loss intervention (WLI) on quality of life (QOL) and symptoms in women with breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.2026-05-27
  Vered Stearns
  arXiv ↗
• Association of the 70-gene assay and homologous recombination deficiency in patients with high risk 2 breast cancers.2026-05-27
  M Cristofanilli
  arXiv ↗
• Results from a phase 2a study of atebimetinib in combination with mGnP in advanced or metastatic pancreatic cancer.2026-05-27
  Anna C. Pavlick, Allyson J. Ocean, Barbara T. Ma
  arXiv ↗
• Efficacy and circulating protein biomarkers of second-line aflibercept plus FOLFIRI according to prior bevacizumab or cetuximab treatment in advanced colorectal cancer (KCSG CO21-21).2026-05-27
  Colin Burdette, Jacob B. Geri
  arXiv ↗
• Long-term safety outcomes of pregnancy among young breast cancer survivors: Results from a prospective, multicenter cohort study.2026-05-27
  Shoshana M. Rosenberg, Rulla Tamimi
  arXiv ↗
• HER2-independent antitumor and pharmacodynamic responses to trastuzumab deruxtecan in patients with advanced solid tumors.2026-05-27
  Cora N. Sternberg
  arXiv ↗
• Phase 2 multicenter trial of chemoimmunotherapy for patients with neuroendocrine or aggressive variant metastatic prostate cancer (CHAMP).2026-05-27
  David M. Nanus, Cora N. Sternberg
  arXiv ↗
• Associations of oral contraceptives with expression of CD44, CD24, and ALDH1A1 stem cell markers in women with benign breast biopsies2026-05-27
  Rulla M. Tamimi
  arXiv ↗
• Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers2026-05-21
  Shari B. Goldfarb, Benjamin D. Greenbaum
  arXiv ↗
• Comparison of early-onset and average-onset colorectal cancer in Saudi Arabia: A multicenter retrospective cohort study2026-05-19
  S A Alqahtani
  arXiv ↗
• First-in-class small molecule ROBO2 binders identified through integrated virtual screening and biophysical validation2026-05-19
  Kirti Upmanyu, Hossam Nada, Moustafa T. Gabr
  arXiv ↗
• A National Survey-Based Study of Factors Influencing Dermatologists Performing Nail Biopsies2026-05-18
  Rachel C. Hill, Shari R. Lipner
  arXiv ↗
• Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity2026-05-16
  Mahinur Mattohti
  arXiv ↗
• Tie2 inhibition disrupts TMEM doorway function and reduces dissemination in pancreatic ductal adenocarcinoma2026-05-16
  Nicole C. Panarelli
  arXiv ↗
• Engineering lymphatic vessels and lymphoid microenvironments in vitro to investigate immune cell trafficking2026-05-15
  Elizabeth Oh, Esak Lee
  arXiv ↗
• Preoperative hypoalbuminemia and survival among patients selected for primary cytoreduction in advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study2026-05-15
  Vance Broach, K. Long, Ginger J. Gardner, Yukio Sonoda, Nadeem R. Abu-Rustum, Dennis S. Chi
  arXiv ↗
• Political determinants of melanoma: Global inequities in skin cancer care2026-05-14
  Shari Lipner
  arXiv ↗
• A multi-omic, spatial, and whole-slide image dataset of lung neuroendocrine tumours from the lungNENomics cohort2026-05-14
  Z Li, Jaehee Kim
  arXiv ↗
• Pregnancy history, recency of childbirth, and outcomes in young women with early-stage breast cancer2026-05-14
  Shoshana M Rosenberg, Laura C. Collins
  arXiv ↗
• Optimizing Breast Cancer Survivorship: Addressing Lifestyle, Weight Management, and Psychological Health2026-05-13
  Jane Chen
  arXiv ↗
• EMA-Pal: Co-Creating a Remote Symptom Assessment Platform for Palliative Care2026-05-12
  Daniel Shalev, Emily Bivona-Maldonado, Maureen Ekwebelem, Zilong Yu, Daphne Buitron, Samprit Banerjee
  arXiv ↗
• Pancreatic MRI Findings in High-Risk Individuals Compared with Matched Average-Risk Individuals2026-05-11
  J Faiz, Xiaohong Jin
  arXiv ↗
• Dimensionality Impacts Effect Of Estradiol On Breast Cancer Cell Behavior2026-05-09
  Matthew Liao, Samuel Medina, Olivia Carrafiell, Gabrielle Kupferman, Paul Kim, Steven Danilav-Lee, Xue Dong, Jason Spector
  arXiv ↗
• Advancing Skin-tone Equity In Contactless Flap And Graft Monitoring: A Scoping Review And The Ster-8 Checklist2026-05-09
  Joclin Rabinovich
  arXiv ↗
• Dimensionality Impacts Effect Of Estradiol On Breast Cancer Cell Behavior2026-05-09
  Matthew Liao, Samuel J. Medina, Olivia H. Carrafiell, Gabrielle S. Kupferman, Paul K. Kim, Steven Danilav-Lee, Xue Dong, Jason A. Spector
  arXiv ↗